Steven V Manoukian
Affiliation: Emory University
- Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY TrialSteven V Manoukian
Department of Medicine, Emory University School of Medicine, Atlanta, Georgia 30308, USA
J Am Coll Cardiol 49:1362-8. 2007..The purpose of this study was to determine the predictors of major bleeding and the impact of major bleeding on outcomes, including mortality, in acute coronary syndromes (ACS)...
- Bleeding complications in acute coronary syndromes and percutaneous coronary intervention: predictors, prognostic significance, and paradigms for reducing riskSteven V Manoukian
Interventional Cardiology, Emory University School of Medicine, Atlanta, Georgia 30308, USA
Clin Cardiol 30:II24-34. 2007....
- Safety and efficacy of bivalirudin monotherapy in patients with diabetes mellitus and acute coronary syndromes: a report from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trialFrederick Feit
Division of Cardiology, Department of Medicine, New York University School of Medicine, New York, New York, USA
J Am Coll Cardiol 51:1645-52. 2008..We sought to evaluate clinical outcomes of patients with diabetes mellitus in the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial, overall and by treatment arm...
- Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 TrialFrederick Feit
Department of Medicine, New York University School of Medicine, New York, NY, USA
Am J Cardiol 100:1364-9. 2007..A number of baseline and periprocedural factors independently predicted major hemorrhage, including treatment with heparin plus GPI...
- The evolving role of glycoprotein IIb/IIIa inhibitors in the setting of percutaneous coronary intervention strategies to minimize bleeding risk and optimize outcomesElias B Hanna
Department of Medicine, Cardiovascular Section, Louisiana State University, 1542 Tulane Avenue, New Orleans, LA 70112, USA
JACC Cardiovasc Interv 3:1209-19. 2010..This review provides an update of the current literature that supports these measures, an insight on the tailored use of GPI, and a potential direction for future research addressing combined antithrombotic therapies...
- Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trialRamin Ebrahimi
University of California Los Angeles and the Greater Los Angeles VA Medical Center, Department of Medicine, Cardiology Section 111E, Los Angeles, California 90073, USA
J Am Coll Cardiol 53:1965-72. 2009....
- Effect of anemia on hemorrhagic complications and mortality following percutaneous coronary interventionMichele D Voeltz
Department of Medicine, Division of Cardiology, Emory University School of Medicine, Atlanta, Georgia, USA
Am J Cardiol 99:1513-7. 2007....
- Impact of the definition utilized on the rate of contrast-induced nephropathy in percutaneous coronary interventionRefat Jabara
Saint Joseph s Cardiovascular Research Institute Saint Joseph s Hospital of Atlanta, Atlanta, Georgia, USA
Am J Cardiol 103:1657-62. 2009..The wide variation in CIN and its lack of association with adverse outcomes underscore the need for a standardized, clinically relevant definition...
- The important properties of contrast media: focus on viscosityMichele D Voeltz
Emory University School of Medicine, Atlanta, GA, USA
J Invasive Cardiol 19:1A-9A. 2007
- Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trialGregg W Stone
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY 10022, USA
Lancet 369:907-19. 2007..The aim of this study was to assess anticoagulation with the direct thrombin inhibitor bivalirudin during percutaneous coronary intervention in individuals with moderate and high-risk acute coronary syndromes...
- Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trialGregg W Stone
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York 10022, USA
JAMA 298:2497-506. 2007....
- Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Intervention TriaHarvey D White
Green Lane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand
J Am Coll Cardiol 52:807-14. 2008..This study was designed to determine the impact of bivalirudin on 1-year outcomes in acute coronary syndrome (ACS) patients undergoing percutaneous coronary intervention (PCI)...
- Bleeding is bad.... isn't it?Peter B Berger
Circulation 116:2776-8. 2007